THU0232 DIFFERENTIAL METHYLATION OF IL8 AND TISSUE FACTOR PROMOTER IN ANTIPHOSPHOLIPID SYNDROME
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.5459
Abstract: Background: Antiphospholipid syndrome (APS) is an autoimmune thrombophillia characterized by recurrent thromboembolism and/or pregnancy morbidity in the presence of Antiphospholipid antibodies mainly anti-β2glycoprotein I (anti-β2GPI), which lead to monocyte and endothelial cell activation and subsequent… read more here.
Keywords: methylation; tissue factor; il8; promoter ... See more keywords
Combining TMZ and SB225002 induces changes of CXCR2 and VEGFR signalling in primary human endothelial cells in vitro
Sign Up to like & getrecommendations! Published in 2022 at "Oncology Reports"
DOI: 10.3892/or.2022.8373
Abstract: Standard of care therapy for glioblastoma (GBM) consisting of surgical removal, temozolomide (TMZ) and radiotherapy fails to cure the disease and median survival is limited to 15 months. Therapeutic approaches targeting vascular endothelial growth factor… read more here.
Keywords: endothelial cells; il8; expression; cxcr2 ... See more keywords